GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » EPS (Basic)

Joincare Pharmaceutical Group Industry Co (SHSE:600380) EPS (Basic) : ¥0.75 (TTM As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co EPS (Basic)?

Joincare Pharmaceutical Group Industry Co's basic earnings per share (Basic EPS) for the three months ended in Jun. 2024 was ¥0.18. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥0.75.

Joincare Pharmaceutical Group Industry Co's EPS (Diluted) for the three months ended in Jun. 2024 was ¥0.18. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥0.75.

Joincare Pharmaceutical Group Industry Co's EPS without NRI for the three months ended in Jun. 2024 was ¥0.22. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 0.91.

During the past 12 months, Joincare Pharmaceutical Group Industry Co's average EPS without NRIGrowth Rate was 4.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 13.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Joincare Pharmaceutical Group Industry Co's highest 3-Year average EPS without NRI Growth Rate was 88.30% per year. The lowest was -30.70% per year. And the median was 15.30% per year.


Joincare Pharmaceutical Group Industry Co EPS (Basic) Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co EPS (Basic) Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.58 0.69 0.79 0.76

Joincare Pharmaceutical Group Industry Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.14 0.19 0.24 0.18

Joincare Pharmaceutical Group Industry Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Joincare Pharmaceutical Group Industry Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1442.78-0)/1903.403
=0.76

Joincare Pharmaceutical Group Industry Co's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(336.626-0)/1868.682
=0.18

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Joincare Pharmaceutical Group Industry Co  (SHSE:600380) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Joincare Pharmaceutical Group Industry Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co Business Description

Traded in Other Exchanges
N/A
Address
No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Xie You Guo Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co Headlines

No Headlines